Evidence-Based Treatments and Prescription Variability after Acute Myocardial Infarction

被引：0
|
作者：
Marco Bobbio
Massimo Imazio
Massimo Tidu
机构：
[1] University Cardiology Department,
[2] Department of Medicine,undefined
[3] Molinette Hospital,undefined
[4] University of Turin,undefined
来源：
Clinical Drug Investigation | 1999年 / 17卷
关键词：
Aspirin; Adis International Limited; Acute Myocardial Infarction; Acute Myocardial Infarction; Calcium Antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Since there is growing interest in the prescribing of different drugs in various clinical settings, the aim of the study was to verify whether drug prescribing after acute myocardial infarction can be explained on the basis of evidence-based treatment.
引用
收藏
页码：241 / 250
页数：9
相关论文
共 50 条
  • [21] IIb/IIIa inhibitors in acute myocardial infarction: Evidence-based indications for use
    Block, PC
    HEART DISEASE: NEW TRENDS IN RESEARCH, DIAGNOSIS AND TREATMENT, 2001, : 243 - 246
  • [22] Monitoring of quality indicators of prescription after acute myocardial infarction
    Aznarte Padial, P.
    Perez Vicente, S.
    Zarzuelo Zurita, A.
    Calleja Hernandez, M. A.
    REVISTA DE CALIDAD ASISTENCIAL, 2012, 27 (03) : 155 - 160
  • [23] Use of Cardiovascular Drugs After Acute Myocardial Infarction: A Marked Shift Towards Evidence-Based Drug Therapy
    Åsmund Reikvam
    Elena Kvan
    Ivar Aursnes
    Cardiovascular Drugs and Therapy, 2002, 16 : 451 - 456
  • [24] Evidence-Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
    Lee, Kyusup
    Han, Seungbong
    Lee, Myunhee
    Kim, Dae-Won
    Kwon, Jongbum
    Park, Gyung-Min
    Park, Mahn-Won
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [25] Use of cardiovascular drugs after acute myocardial infarction:: A marked shift towards evidence-based drug therapy
    Reikvam, Å
    Kvan, E
    Aursnes, I
    CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (05) : 451 - 456
  • [26] Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
    Rasmussen, Jeppe N.
    Chong, Alice
    Alter, David A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02): : 177 - 186
  • [27] Long term adherence to evidence-based cardioprotective medications after acute myocardial infarction and its impact on mortality
    Hamood, H.
    Hamood, R.
    Almog, R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1151 - 1152
  • [28] Adherence to evidence-based statin guidelines reduces risk for acute myocardial infarction by 40%
    Penning-van Beest, Fernie J. A.
    Goettsch, Wim G.
    Klungel, Olaf H.
    Kastelein, John J. P.
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S293 - S294
  • [29] Effect of age on administration of evidence-based therapies for acute myocardial infarction over time
    Perschbacher, JM
    Reeder, GS
    Jacobsen, SJ
    Weston, S
    Meverden, R
    Roger, VL
    CIRCULATION, 2003, 107 (07) : E7032 - E7032
  • [30] Application of evidence-based nursing in patients with acute myocardial infarction complicated with heart failure
    Zhou, Yanyun
    Wang, Xuan
    Lan, Shanshan
    Zhang, Li
    Niu, Guixia
    Zhang, Guiqin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 5641 - 5646
12345